Orbital cancer

disease
On this page

Also known as cancer of orbit of skullmalignant neoplasm of orbitmalignant neoplasm of orbit of skullmalignant neoplasm of the orbitmalignant orbit neoplasmmalignant orbit of skull neoplasmmalignant orbit tumormalignant orbit tumourmalignant orbital neoplasmmalignant orbital tumormalignant orbital tumourmalignant tumor of orbitmalignant tumor of the orbitmalignant tumour of orbitmalignant tumour of the orbitneoplasm of orbit properorbit of skull cancerorbital tumororbital tumour

Summary

Orbital cancer (MONDO:0002889) is a cancer and 6 clinical trials. A subtype of skull cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer
  • Clinical trials: 6

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameorbital cancer
Mondo IDMONDO:0002889
EFOEFO:0007408
DOIDDOID:4143
ICD-10-CMC69.6
ICD-111872149350
NCITC3562
SNOMED CT127003006
UMLSC0153626
MedGen56314
GARD0023289
Anatomy (UBERON)UBERON:0001697
Is cancer (heuristic)yes

Also known as: cancer of orbit of skull · malignant neoplasm of orbit · malignant neoplasm of orbit of skull · malignant neoplasm of the orbit · malignant orbit neoplasm · malignant orbit of skull neoplasm · malignant orbit tumor · malignant orbit tumour · malignant orbital neoplasm · malignant orbital tumor · malignant orbital tumour · malignant tumor of orbit · malignant tumor of the orbit · malignant tumour of orbit · malignant tumour of the orbit · neoplasm of orbit proper · orbit of skull cancer · orbital tumor · orbital tumour

Disease family

An umbrella term covering 2 Mondo subtypes.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disordermusculoskeletal system cancerbone cancer › skull cancer › orbital cancer

Related subtypes (5): pituitary cancer, jaw cancer, skull base chordoma, malignant jugulotympanic paraganglioma, paranasal sinus cancer

Subtypes (2): orbit lymphoma, orbit sarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 6.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified6

Top trials by phase / activity

NCTPhaseStatusTitle
NCT01884207Not specifiedCOMPLETEDMultiparametric Characterization of Orbital Tumors by MRI
NCT02401906Not specifiedCOMPLETEDMRI and Orbital Tumours (MEDORT)
NCT02434120Not specifiedCOMPLETEDMRI Perfusion Curves Typology and Orbital Tumors (PERFORM)
NCT03195101Not specifiedUNKNOWNEvaluation of Transconjunctival Approach in Management of Orbital Tumors
NCT04704414Not specifiedUNKNOWNExophthalmometry With 3D Face Scanners
NCT05613244Not specifiedCOMPLETEDDescriptive Study of a Cohort of Orbital Solitary Fibrous Tumors

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.